UPC Analytics
ENDE
Overview · Filed: —

UPC_CFI_283/2026

Methods of Using Sustained Release Aminopyridine Compositions

Procedural & sub-applicationsDocument Access (RoP262)Paris LDApplication RoP262.1 (b)—
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • Gowling WLG
Reps: Marianne Schaffner (Gowling WLG)

Respondents

  • Merz Therapeutics GmbH
  • Merz Pharmaceuticals LLC
  • Merz Pharma France
  • Viatris Santé
Reps: Laëtitia Bénard; Marc Lauzeral
Judges

French-seated division — individual judges anonymized.

  • Panel member (anonymized)Judge-rapporteur, Paris Local Division
Patents
  • EP 2 377 536
CPC codes: A61P43/00, A61P19/08, A61K31/435, A61P25/28, A61K9/20, A61K31/44, A61P21/00, A61P17/02, A61K31/4409, A61P25/00

Sector: Pharmaceutical & Medical

Outcome
Procedural only
Filed: —
First decided: Feb 19, 2026
Language: —